For the financial year ended 31 December 2015
109
ANNUAL REPORT 2015
29. SIGNIFICANT COMPANIES IN THE GROUP
(CONTINUED)
Notes
(i) Companies indicated with a (*) are indirectly held by Haw Par Corporation Limited.
(ii) Companies indicated with a (+) are audited by PricewaterhouseCoopers member firms outside Singapore.
(iii) Companies indicated with a (++) are audited by other firms. These foreign-incorporated companies are not
considered as significant foreign-incorporated subsidiaries under the Singapore Exchange Securities Trading
Limited - Listing Rules. Accordingly, Rule 716 of the Listing Manual has been complied with.
(iv) The company indicated with a (#) is listed on an overseas stock exchange and audited by other firm of auditors.
During the financial year ended 31 December 2015, the company was reclassified from investment in associated
company to available-for-sale financial assets (Note 13).
(v) All the above subsidiaries and associated companies operate in their respective countries of incorporation except
Hua Han Health Industries Holdings Limited which operates mainly in the People’s Republic of China.
30. AUTHORISATION OF FINANCIAL STATEMENTS
These financial statements are authorised for issue in accordance with a resolution of the Board of Directors of Haw Par
Corporation Limited on 25 February 2016.
NOT E S TO T H E F I NAN C I A L S TAT EME N T S
(CONTINUED)
